Singapore markets close in 6 hours 25 minutes

Nuvation Bio Inc. (NUVB)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
9.05+0.04 (+0.44%)
At close: 04:00PM EST
9.05 0.00 (0.00%)
After hours: 06:03PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 1.97B
Enterprise value 1.97B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)2.55
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-11.45%
S&P500 52-week change 322.93%
52-week high 315.23
52-week low 37.30
50-day moving average 39.35
200-day moving average 310.24

Share statistics

Avg vol (3-month) 3759.87k
Avg vol (10-day) 31.31M
Shares outstanding 5217.79M
Implied shares outstanding 6217.76M
Float 8119.31M
% held by insiders 127.16%
% held by institutions 168.19%
Shares short (14 Nov 2021) 48.59M
Short ratio (14 Nov 2021) 413.85
Short % of float (14 Nov 2021) 410.09%
Short % of shares outstanding (14 Nov 2021) 43.94%
Shares short (prior month 14 Oct 2021) 48.85M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sep 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-10.79%
Return on equity (ttm)-17.42%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -77.31M
Net income avi to common (ttm)-97.62M
Diluted EPS (ttm)-0.45
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)791.78M
Total cash per share (mrq)3.64
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)59.86
Book value per share (mrq)3.53

Cash flow statement

Operating cash flow (ttm)-57.65M
Levered free cash flow (ttm)-38.17M